During the summer of 2021, the Delta variant was causing a surge in COVID-19 cases. Many people wondered if the vaccines were still holding up. A study looking at veterans at five VA medical centers found that the mRNA vaccines—like those from Pfizer and Moderna—continued to show high effectiveness at preventing COVID-19 hospitalizations during that time. The research tracked veterans from February through August 2021, a period when Delta became the dominant strain. It's important to note this was an observational study, meaning it looked at real-world data rather than a controlled experiment. The researchers didn't report specific numbers on exactly how much protection the vaccines provided, or how many people were involved. But the core finding—that effectiveness remained high—is a meaningful piece of evidence, especially for a population like veterans who may have other health conditions. The study didn't report on safety issues or side effects during this period.
Did COVID-19 vaccines keep protecting veterans from hospitalization?
Photo by Navy Medicine / Unsplash
What this means for you:
Vaccines showed sustained power to prevent severe COVID-19 in veterans during the Delta wave. More on COVID-19
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders Clozapine users faced higher risk of severe COVID-19 in large study
· May 1, 2026
Inactivated SARS-CoV-2 vaccine dosing schedules and antibody responses in adults aged 60 to 80 years Older adults get better protection with the right vaccine booster timing
Frontiers · Apr 30, 2026
Survey finds physicians show stronger intergroup bias than public on vaccines Doctors Show Strong Bias Against Vaccine-Hesitant Patients
medRxiv · Apr 26, 2026
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
CT.gov · Apr 24, 2026